Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Women's Issues in Multiple Sclerosis.
Understanding the Role of T Cells in CNS Homeostasis.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Timing of birth and risk of multiple sclerosis: population based study.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Clinically isolated syndromes.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Pages
« first
‹ previous
…
73
74
75
76
77
78
79
80
81
…
next ›
last »